The objectives of this review are to highlight GARP expression, regulation, and function in Treg, other immune cells, and cancer cells as well as to evaluate the potential of both surface and soluble GARP as predictive and therapeutic biomarkers. This evidence concerns the gene LRRC32 and cancer.